Prosecution Insights
Last updated: April 19, 2026

AltaThera Pharmaceuticals LLC

8 pending office actions

Portfolio Summary

8
Total Pending OAs
2
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18417748 METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 1628 Non-Final OA Jan 19, 2024
18324703 METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL BARSKY, JARED 1628 Non-Final OA May 26, 2023
18323337 METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 3783 Non-Final OA May 24, 2023
18322111 METHOD OF INITIATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 1628 Non-Final OA May 23, 2023
18121980 DOFETILIDE DRUG DOSING METHODS AND SYSTEMS AND PRESCRIPTION DRUG USE RELATED SOFTWARE MENDEZ, MANUEL A 3783 Non-Final OA Mar 15, 2023
18107785 ANTIARRHYTHMIC DRUG DOSING METHODS AND SYSTEMS AND PRESCRIPTION DRUG USE RELATED SOFTWARE MENDEZ, MANUEL A 3783 Non-Final OA Feb 09, 2023
17861226 METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 1628 Final Rejection Jul 10, 2022
17306490 METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE NGUYEN, JOHN P 1619 Final Rejection May 03, 2021

Managing AltaThera Pharmaceuticals LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month